High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

Table 1 Chemotherapy regimens for lymphoma

Types of lymphoma	Chemotherapy regimens	Number of patients	Chemotherapy cycle (days)/time	Dose intensity of PLD(mg/m²)
NHL	CDOP	19	21/d1	30
	CDOP	30		40
	R-CDOP	31	21/d2	30
	R-CDOP	42		40
	CDOPE	3	21/d1	30
	CDOPE	7		40
	R-CDOPE	3	21/d2	30
	R-CDOPE	4		40
	PDD	1	21/d1	40
	VRCDOP	2	21/d2	30
	VRCDOP	1		40
HL	ABVD	24	28/d1,d15	40/d1and d15

*Abbreviations: NHL Non-Hodgkin’s lymphoma, HL Hodgkin’s lymphoma, R-CDOP (rituximab, cyclophosphamide, PLD, vincristine, prednisone), CDOP (cyclophosphamide, PLD, vincristine, prednisone), CDOPE (cyclophosphamide, PLD, vincristine, prednisone, etoposide), PDD (bortezomib, PLD, dexamethasone), VRCDOP (bortezomib, rituximab, cyclophosphamide, PLD, vincristine, prednisone), ABVD (PLD, bleomycin, vinblastine, dacarbazine)

ISSN: 2050-6511